Axsome acquires Avenue's subsidiary for epilepsy drug development
Go back to Axsome acquires Avenue's subsidiary for epilepsy drug development| (NASDAQ: ATXI) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $ | |||
| Open | $0.42 | 52 Week Low | $ | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $ | |||
| Volume | 686 | |||||
| (NASDAQ: AXSM) | Delayed: 250.50 -1.66 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $252.16 | 52 Week High | $15.74 | |||
| Open | $255.62 | 52 Week Low | $5.37 | |||
| Day High | $260.19 | P/E | N/A | |||
| Day Low | $247.34 | EPS | $0.00 | |||
| Volume | 770,864 | |||||
| Fabien Corp (NASDAQ: FBIO) | Delayed: 2.99 -0.08 (2.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.07 | 52 Week High | $4.66 | |||
| Open | $3.14 | 52 Week Low | $2.01 | |||
| Day High | $3.16 | P/E | N/A | |||
| Day Low | $2.98 | EPS | $0.00 | |||
| Volume | 372,256 | |||||

